Latest 10-K annual reports
NASDAQ
PLUS
Eplus INCe Plus inc. reports its annual results, highlighting strategic acquisitions and service expansion amidst economic challenges, with a focus on security, cloud, and AI solutions.
NASDAQ
Replimune Group outlines its capital stock composition, including common and preferred shares, pre-funded warrants, and provisions designed to deter unsolicited acquisitions in its recent 10-K filing.
NYSE
Under Armour reports a 9.4% decrease in total net revenues for fiscal year 2025, driven by challenges in North America and Asia-Pacific, while implementing a restructuring plan to improve financial efficiencies.
Nongfu Shop Digital New Retail Co., Ltd., formerly Yong Bai Chao New Retail Corporation, files an amended 10-K/A to include an updated audit report and reflect the company's name change, while continuing its search for a business combination target.
NASDAQ
World Acceptance Corporation reports a 16% increase in net income for fiscal year 2025, while managing regulatory changes and focusing on strategic growth.
NYSE
10-K: Dynatrace Reports Strong Fiscal Year 2025 Results, Driven by AI-Powered Observability Platform
Dynatrace's fiscal year 2025 shows significant growth in revenue and ARR, fueled by its AI-powered observability platform and strategic customer expansions.
OQB
Polomar Health Services' annual report highlights a strategic shift towards specialty pharmacy operations following a merger, while addressing financial challenges and future growth plans.
NASDAQ
EGHT
8x8 INC /DE/8x8, Inc. announces its fiscal year 2025 results, highlighting a strategic focus on mid-market and enterprise customers amidst debt management and evolving market dynamics.
OQB
Anvi Global Holdings' annual report reveals ongoing losses, accumulated deficit, and substantial doubt about its ability to continue as a going concern.
NYSE
VFC
V F CORPVF Corporation reports a 4% revenue decrease for Fiscal 2025, but highlights progress in its Reinvent turnaround program and improved gross margins.
NYSE
Thermon Group Holdings reports a slight increase in revenue for fiscal year 2025, driven by strategic acquisitions, while navigating macroeconomic uncertainties.
NYSE
10-K: Ralph Lauren Reports Strong Fiscal 2025 Results, Driven by International Growth and Brand Elevation
Ralph Lauren Corporation's Fiscal 2025 10-K filing reveals a year of solid growth, fueled by international expansion and a strategic focus on brand elevation, despite ongoing global economic uncertainties.
NASDAQ
Allegro MicroSystems faced a challenging fiscal year 2025 marked by a significant revenue decline due to market headwinds, while implementing strategic initiatives to optimize costs and position for future growth.
CSW Industrials' fiscal year 2025 saw a 10.8% increase in net revenues, fueled by organic growth and strategic acquisitions, with a focus on niche, value-added products.
NASDAQ
Nextracker Inc. announces its fiscal year 2025 results, highlighting revenue growth and strategic acquisitions to expand its solar technology platform.
NASDAQ
CELU
Celularity INCCelularity Inc. files an amendment to its 2024 annual report on Form 10-K/A, focusing on Part III disclosures related to directors, executive officers, compensation, and corporate governance.
NYSE
LiveRamp Holdings, Inc. releases its 10-K filing, detailing its financial performance for fiscal year 2025 and outlining its strategic initiatives for future growth in the data collaboration space.
OQB
International Land Alliance reports net income of $3.0 million for 2024 but acknowledges substantial doubt about its ability to continue as a going concern due to liquidity shortages and accumulated deficits.
NASDAQ
FLEX
Flex LTD10-K: Flex Ltd. Reports Fiscal Year 2025 Results, Navigates Supply Chain and Geopolitical Challenges
Flex Ltd. announces its fiscal year 2025 results, highlighting strategic acquisitions and adaptations to global economic uncertainties.
NASDAQ
10-K: American Superconductor Reports Profitable Fiscal Year 2024, Fueled by Grid and Wind Segment Growth
American Superconductor achieved profitability in fiscal year 2024, driven by significant revenue increases in both its Grid and Wind business segments.
NYSE
ENS
EnersysEnerSys's fiscal year 2025 saw a slight revenue increase driven by acquisitions, with strategic shifts and cost management initiatives shaping the company's performance.
NYSE
10-K: Modine Manufacturing Reports 7% Sales Increase in Fiscal 2025, Driven by Climate Solutions Segment
Modine Manufacturing's fiscal 2025 saw a 7% increase in net sales, primarily driven by growth in the Climate Solutions segment, particularly in data center cooling.
NYSE
Haemonetics Corporation's fiscal 2025 results show a 4.0% increase in net revenues, driven primarily by growth in the Hospital segment, while Plasma and Blood Center segments experienced declines.
NASDAQ
KOPN
Kopin CORPKopin Corporation amended its annual report on Form 10-K to correct certain amounts within Item 11, Executive Compensation, including the Summary Compensation Table.
NASDAQ
10-K/A: ADTRAN Holdings Restates Financials After Audit Uncovers Inventory Adjustment, Material Weaknesses
ADTRAN Holdings files an amended 10-K to restate prior financial statements due to an inventory adjustment at its Adtran Networks subsidiary and the identification of material weaknesses in internal controls.
NYSE
Eagle Materials Inc. announces record revenue and diluted earnings per share for fiscal year 2025, highlighting strategic acquisitions and expansion projects.
NYSE
Finance of America Companies Inc. is restating its 2024 annual report due to errors in the classification and presentation of cash flows related to nonrecourse securitization transactions.
OTC.Pink
Burzynski Research Institute reports its fiscal year 2025 results, highlighting ongoing research and development efforts despite a full clinical hold on its IND 43742.
NASDAQ
POWW
Ammo, INC10-K/A: Outdoor Holding Company Restates Financials, Cites Accounting Errors and Management Oversight
Outdoor Holding Company (formerly AMMO, Inc.) files an amendment to its annual report, restating financial statements due to accounting errors and disclosing a special committee investigation.
NYSE
DOCS
Doximity, INCDoximity's fiscal year 2025 shows revenue growth and profitability, fueled by its expanding network of medical professionals and increasing customer subscriptions.